Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pinilla-Ibarz JA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Neil Gallagher, Javier Pinilla-Ibarz, Philipp le Coutre, Andreas Hochhaus, Oliver G. Ottmann, Dong-Wook Kim, Jerald P. Radich, Rick E. Blakesley, Giovanni Martinelli, Michele Baccarani, Yaping Shou, Hagop M. Kantarjian, Jorge E. Cortes, Norbert Gattermann, Richard A. Larson, Francis J. Giles, Kapil N. Bhalla, Timothy P. Hughes, Giuseppe Saglio
Nilotinib is a potent selective inhibitor of the BCR-ABL tyrosine kinase approved for use in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP), and in CML-CP and CML-accelerated phase after imatinib failure. Nilotinib (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa372cd252661d3b89ccc250b701343a
http://hdl.handle.net/11585/96957
http://hdl.handle.net/11585/96957
Autor:
Faramand RG; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Lee SB; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Jain MD; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Cao B; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Wang X; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Rejeski K; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Germany., Subklewe M; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Germany., Fahrmann JF; Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, Texas., Saini NY; Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, Texas., Hanash SM; Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, Texas., Kang YP; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Chang D; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Rodriguez PC; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Dean EA; Division of Hematology and Oncology, University of Florida, Gainesville, Florida., Nishihori T; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Shah BD; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Lazaryan A; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Chavez J; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Khimani F; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Pinilla-Ibarz JA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Dam M; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Reid KM; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Corallo SA; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Menges M; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Hidalgo Vargas M; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Mandula JK; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G James Cancer Hospital and Richard J Solove Research Institute, The Ohio State University, Columbus, Ohio., Holliday BA; University of South Florida School of Medicine, Tampa, Florida., Bachmeier CA; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Speth K; Kite, a Gilead Company, Santa Monica, California., Song Q; Kite, a Gilead Company, Santa Monica, California., Mattie M; Kite, a Gilead Company, Santa Monica, California., Locke FL; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Davila ML; Department of Medical Oncology, Roswell Park Cancer Center, Buffalo, New York.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2024 Mar 01; Vol. 5 (2), pp. 106-113.
Autor:
Lee AC; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA.; Cell & Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Pingali SR; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA., Pinilla-Ibarz JA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Atchison ML; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA., Koumenis C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Argon Y; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Thomas-Tikhonenko A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., De Trez C; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Hu CA; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA. cahu@houstonmethodist.org., Tang CA; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA. catang@houstonmethodist.org.
Publikováno v:
Leukemia [Leukemia] 2022 Oct; Vol. 36 (10), pp. 2430-2442. Date of Electronic Publication: 2022 Aug 30.
Autor:
Tang CA; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA. Ctang@wistar.org., Lee AC; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA., Chang S; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA., Xu Q; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA., Shao A; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA., Lo Y; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA., Spalek WT; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA., Pinilla-Ibarz JA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA., Del Valle JR; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, 46556, USA., Hu CA; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA. Chu@wistar.org.
Publikováno v:
Cellular & molecular immunology [Cell Mol Immunol] 2021 Apr; Vol. 18 (4), pp. 1016-1031. Date of Electronic Publication: 2020 Sep 30.
Autor:
Mato AR; Memorial Sloan Kettering Cancer Center, New York, New York. matoa@mskcc.org., Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York., Jacobs R; Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, North Carolina., Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio., Lamanna N; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York., Brander D; Duke University Medical Center, Durham, North Carolina., Shadman M; Fred Hutchinson Cancer Research Center, Seattle, Washington., Ujjani CS; Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, Washington., Yazdy MS; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington D.C., Perini GF; Hospital Israelita Albert Einstein, Sao Paulo, Pará, Brazil., Pinilla-Ibarz JA; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida., Barrientos J; North Shore University Hospital, Northwell Health, Manhasset, New York., Skarbnik AP; Novant Health, Charlotte, North Carolina., Torka P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Pu JJ; SUNY Upstate Medical University, Syracuse, New York., Pagel JM; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington., Gohil S; University College London, London, United Kingdom., Fakhri B; Department of Medicine, Division of Hematology/Oncology, University of California San Francisco, San Francisco, California., Choi M; Moores Cancer Center, University of California San Diego, La Jolla, California., Coombs CC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Rhodes J; Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Barr PM; Division of Hematology/Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, New York., Portell CA; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia., Parry H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Garcia CA; Hillman Cancer Pavilion, Division of Hematology and Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Whitaker KJ; Memorial Sloan Kettering Cancer Center, New York, New York., Winter AM; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Sitlinger A; Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina., Khajavian S; Fred Hutchinson Cancer Research Center, Seattle, Washington., Grajales-Cruz AF; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida., Isaac KM; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia., Shah P; Northwell Health, New York, New York., Akhtar OS; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Pocock R; University of College of London, London, United Kingdom., Lam K; Moores Cancer Center, University of California San Diego, La Jolla, California., Voorhees TJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Schuster SJ; Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Rodgers TD; University of Rochester Medical Center, Rochester, New York., Fox CP; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Martinez-Calle N; Clinical Haematology Department, Nottingham University Hospitals NHS Trust, Nottingham, England, United Kingdom., Munir T; Weill Cornell Medicine, Long Island City, New York., Bhavsar EB; Department of Haematology, St James's University Hospital, Leeds, United Kingdom., Bailey N; Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, Washington., Lee JC; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York., Weissbrot HB; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York., Nabhan C; Aptitude Health, Atlanta, Georgia., Goodfriend JM; Memorial Sloan Kettering Cancer Center, New York, New York., King AC; Clinical Pharmacy Specialist-Leukemia, Memorial Sloan Kettering Cancer Center, New York, New York., Zelenetz AD; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York., Dorsey C; Memorial Sloan Kettering Cancer Center, New York, New York., Bigelow K; Memorial Sloan Kettering Cancer Center, New York, New York., Cheson BD; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington D.C., Allan JN; Department of Haematology, St James's University Hospital, Leeds, United Kingdom., Eyre TA; Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 15; Vol. 26 (14), pp. 3589-3596. Date of Electronic Publication: 2020 Mar 20.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2014 Jun; Vol. 124 (6), pp. 2585-98. Date of Electronic Publication: 2014 May 08.
Autor:
Kriss CL; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA., Pinilla-Ibarz JA, Mailloux AW, Powers JJ, Tang CH, Kang CW, Zanesi N, Epling-Burnette PK, Sotomayor EM, Croce CM, Del Valle JR, Hu CC
Publikováno v:
Blood [Blood] 2012 Aug 02; Vol. 120 (5), pp. 1027-38. Date of Electronic Publication: 2012 Jun 12.
Autor:
Dubovsky JA; Department of Experimental Therapeutics at H. Lee Moffitt Cancer Center, Tampa, FL 33612-9416, USA., Powers JJ, Gao Y, Mariusso LF, Sotomayor EM, Pinilla-Ibarz JA
Publikováno v:
Leukemia research [Leuk Res] 2011 Sep; Vol. 35 (9), pp. 1193-9. Date of Electronic Publication: 2011 Mar 05.
Autor:
Powers JJ; Department of Immunology and Experimental Therapeutics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA., Dubovsky JA, Epling-Burnette PK, Moscinski L, Zhang L, Mustjoki S, Sotomayor EM, Pinilla-Ibarz JA
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2011 Apr; Vol. 52 (4), pp. 668-79. Date of Electronic Publication: 2011 Jan 27.